Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	9.74e-10	279	79	12	GO:0005096
GeneOntologyMolecularFunction	O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity	MFNG RFNG LFNG	5.96e-08	3	79	3	GO:0033829
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	8.95e-08	507	79	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	8.95e-08	507	79	13	GO:0030695
GeneOntologyMolecularFunction	enzyme activator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D ACVR2B TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.57e-07	656	79	14	GO:0008047
GeneOntologyMolecularFunction	enzyme regulator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D XIAP CCAR2 WFDC8 ACVR2B TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.17e-05	1418	79	17	GO:0030234
GeneOntologyMolecularFunction	folic acid receptor activity	FOLR2 FOLR3	4.62e-05	3	79	2	GO:0061714
GeneOntologyMolecularFunction	molecular function activator activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D ACVR2B TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.10e-04	1233	79	14	GO:0140677
GeneOntologyMolecularFunction	acetylglucosaminyltransferase activity	MFNG RFNG LFNG	8.53e-04	47	79	3	GO:0008375
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.14e-13	109	80	11	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.70e-10	244	80	12	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TTC8 TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	5.14e-10	335	80	13	GO:0043087
GeneOntologyBiologicalProcess	regulation of hydrolase activity	TTC8 TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L TBC1D3D XIAP WFDC8 MMP9 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.12e-07	878	80	16	GO:0051336
GeneOntologyBiologicalProcess	positive regulation of molecular function	TBC1D3E MFNG TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D TLR2 PRKCI MMP9 TBC1D3I RFNG TRIM14 TBC1D3G TBC1D3C TBC1D3B LFNG TBC1D3K TBC1D3F	3.66e-07	1430	80	20	GO:0044093
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.77e-07	499	80	12	GO:0051345
GeneOntologyBiologicalProcess	ureteric peristalsis	TBX3 TBX2	4.45e-05	3	80	2	GO:0072105
GeneOntologyBiologicalProcess	ureter smooth muscle contraction	TBX3 TBX2	4.45e-05	3	80	2	GO:0014849
GeneOntologyBiologicalProcess	positive regulation of Notch signaling pathway	MFNG PRKCI RFNG LFNG	5.32e-05	53	80	4	GO:0045747
GeneOntologyBiologicalProcess	mammary placode formation	TBX3 TBX2	8.87e-05	4	80	2	GO:0060596
GeneOntologyBiologicalProcess	atrioventricular canal morphogenesis	TBX3 TBX2	1.47e-04	5	80	2	GO:1905222
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	TBC1D3E TBC1D3 NF1 TBC1D3H TBC1D3L EGF TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.53e-04	1028	80	13	GO:0043085
GeneOntologyBiologicalProcess	cardiac jelly development	TBX3 TBX2	2.21e-04	6	80	2	GO:1905072
Domain	TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	7.31e-15	49	79	10	SM00164
Domain	RabGAP-TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.71e-14	53	79	10	PF00566
Domain	TBC_RABGAP	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.55e-14	55	79	10	PS50086
Domain	Rab-GTPase-TBC_dom	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.55e-14	55	79	10	IPR000195
Domain	Fringe	MFNG RFNG LFNG	7.28e-08	3	79	3	IPR017374
Domain	Fringe-like	MFNG RFNG LFNG	7.24e-07	5	79	3	IPR003378
Domain	Fringe	MFNG RFNG LFNG	7.24e-07	5	79	3	PF02434
Domain	TBX	TBX3 TBX2	1.77e-05	2	79	2	IPR022582
Domain	TBX	TBX3 TBX2	1.77e-05	2	79	2	PF12598
Domain	BTB	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	1.94e-05	131	79	6	PF00651
Domain	BTB	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	5.97e-05	160	79	6	PS50097
Domain	BTB	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	1.14e-04	180	79	6	SM00225
Domain	BTB/POZ_dom	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	1.33e-04	185	79	6	IPR000210
Domain	SKP1/BTB/POZ	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	1.49e-04	189	79	6	IPR011333
Domain	Folate_rcpt	FOLR2 FOLR3	1.75e-04	5	79	2	IPR004269
Domain	Folate_rcpt-like	FOLR2 FOLR3	4.87e-04	8	79	2	IPR018143
Domain	Folate_rec	FOLR2 FOLR3	4.87e-04	8	79	2	PF03024
Domain	-	EGF STAB1	9.48e-04	11	79	2	2.40.155.10
Domain	GFP-like	EGF STAB1	9.48e-04	11	79	2	IPR023413
Domain	TPR_2	TTC8 TTC27 UNC45A	1.24e-03	50	79	3	PF07719
Domain	TPR_2	TTC8 TTC27 UNC45A	1.24e-03	50	79	3	IPR013105
Domain	LINK	BCAN STAB1	1.34e-03	13	79	2	SM00445
Domain	Link_dom	BCAN STAB1	1.34e-03	13	79	2	IPR000538
Domain	Xlink	BCAN STAB1	1.34e-03	13	79	2	PF00193
Domain	LINK_1	BCAN STAB1	1.34e-03	13	79	2	PS01241
Domain	LINK_2	BCAN STAB1	1.34e-03	13	79	2	PS50963
Domain	SCAN	ZNF202 ZNF75D ZNF446	1.72e-03	56	79	3	SM00431
Domain	-	TTC8 TTC23L TTC27 UNC45A CFAP46	1.85e-03	207	79	5	1.25.40.10
Domain	SCAN_BOX	ZNF202 ZNF75D ZNF446	1.90e-03	58	79	3	PS50804
Domain	Kelch	KLHL2 KLHL25 KBTBD11	1.90e-03	58	79	3	SM00612
Domain	SCAN	ZNF202 ZNF75D ZNF446	1.90e-03	58	79	3	PF02023
Domain	SCAN_dom	ZNF202 ZNF75D ZNF446	1.90e-03	58	79	3	IPR003309
Domain	Retrov_capsid_C	ZNF202 ZNF75D ZNF446	2.00e-03	59	79	3	IPR008916
Domain	Gal_Oxase/kelch_b-propeller	KLHL2 KLHL25 KBTBD11	2.00e-03	59	79	3	IPR011043
Domain	TF_T-box	TBX3 TBX2	2.31e-03	17	79	2	IPR001699
Domain	TBOX	TBX3 TBX2	2.31e-03	17	79	2	SM00425
Domain	TF_T-box_CS	TBX3 TBX2	2.31e-03	17	79	2	IPR018186
Domain	-	TBX3 TBX2	2.31e-03	17	79	2	2.60.40.820
Domain	TBOX_3	TBX3 TBX2	2.31e-03	17	79	2	PS50252
Domain	T-box	TBX3 TBX2	2.31e-03	17	79	2	PF00907
Domain	TBOX_1	TBX3 TBX2	2.31e-03	17	79	2	PS01283
Domain	TBOX_2	TBX3 TBX2	2.31e-03	17	79	2	PS01264
Domain	Fd_Rdtase_FAD-bd	CYB5RL NOX3	2.88e-03	19	79	2	IPR017927
Domain	FAD_FR	CYB5RL NOX3	2.88e-03	19	79	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	CYB5RL NOX3	2.88e-03	19	79	2	IPR017938
Domain	TPR-like_helical_dom	TTC8 TTC23L TTC27 UNC45A CFAP46	3.08e-03	233	79	5	IPR011990
Domain	Kelch_1	KLHL2 KLHL25 KBTBD11	3.25e-03	70	79	3	PF01344
Domain	Kelch_1	KLHL2 KLHL25 KBTBD11	3.25e-03	70	79	3	IPR006652
Domain	C2H2_Znf_fam	ZNF202 ZNF446	4.59e-03	24	79	2	IPR027775
Domain	TPR_REGION	TTC8 TTC27 UNC45A CFAP46	5.28e-03	165	79	4	PS50293
Domain	TPR	TTC8 TTC27 UNC45A CFAP46	5.28e-03	165	79	4	PS50005
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K	7.63e-10	99	66	9	M46448
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	MFNG RFNG LFNG	7.61e-05	18	66	3	M614
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	4.65e-30	11	80	11	16863688
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3G TBC1D3B TBC1D3F	4.14e-10	74	80	7	16625196
Pubmed	Lunatic, Manic, and Radical Fringe Each Promote T and B Cell Development.	MFNG RFNG LFNG	1.17e-08	3	80	3	26608918
Pubmed	Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats.	MFNG RFNG LFNG	1.17e-08	3	80	3	16221665
Pubmed	Differential expression pattern of the three Fringe genes is associated with epidermal differentiation.	MFNG RFNG LFNG	1.17e-08	3	80	3	9804358
Pubmed	Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.	MFNG RFNG LFNG	4.68e-08	4	80	3	19026002
Pubmed	Radical and lunatic fringes modulate notch ligands to support mammalian intestinal homeostasis.	MFNG RFNG LFNG	4.68e-08	4	80	3	29629872
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3 TBC1D3D TBC1D3F	4.68e-08	4	80	3	12359748
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3 TBC1D3D TBC1D3F	4.68e-08	4	80	3	8406013
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	1.17e-07	5	80	3	12604796
Pubmed	Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila.	MFNG RFNG LFNG	1.17e-07	5	80	3	9207795
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3 TBC1D3D TBC1D3F	1.17e-07	5	80	3	8471161
Pubmed	Deciphering the Fringe-Mediated Notch Code: Identification of Activating and Inhibiting Sites Allowing Discrimination between Ligands.	MFNG RFNG LFNG	2.33e-07	6	80	3	28089369
Pubmed	Demarcation of early mammalian cortical development by differential expression of fringe genes.	MFNG RFNG LFNG	2.33e-07	6	80	3	10675782
Pubmed	Manic fringe is not required for embryonic development, and fringe family members do not exhibit redundant functions in the axial skeleton, limb, or hindbrain.	MFNG RFNG LFNG	4.07e-07	7	80	3	19479951
Pubmed	Genomic structure, mapping, and expression analysis of the mammalian Lunatic, Manic, and Radical fringe genes.	MFNG RFNG LFNG	6.51e-07	8	80	3	10341080
Pubmed	Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1.	MFNG RFNG LFNG	9.75e-07	9	80	3	15574878
Pubmed	A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway.	MFNG RFNG LFNG	1.91e-06	11	80	3	9187150
Pubmed	Localisation of members of the notch system and the differentiation of vibrissa hair follicles: receptors, ligands, and fringe modulators.	MFNG RFNG LFNG	1.91e-06	11	80	3	10878608
Pubmed	The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development.	MFNG RFNG LFNG	4.19e-06	14	80	3	23806616
Pubmed	The Drosophila ZNRF1/2 homologue, detour, interacts with HOPS complex and regulates autophagy.	ZNRF1 ZNRF2	5.23e-06	2	80	2	38360932
Pubmed	A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice.	TLR2 MMP9	5.23e-06	2	80	2	19667087
Pubmed	Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD.	TLR2 MMP9	5.23e-06	2	80	2	23606791
Pubmed	Gardnerella vaginalis induces matrix metalloproteinases in the cervicovaginal epithelium through TLR-2 activation.	TLR2 MMP9	5.23e-06	2	80	2	35679790
Pubmed	Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier.	FOLR2 FOLR3	5.23e-06	2	80	2	8307991
Pubmed	The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.	TBX3 TBX2	5.23e-06	2	80	2	23388722
Pubmed	Identification of TBX2 and TBX3 variants in patients with conotruncal heart defects by target sequencing.	TBX3 TBX2	5.23e-06	2	80	2	30223900
Pubmed	Effects of dietary folate intake and folate binding protein-2 (Folbp2) on urinary speciation of sodium arsenate in mice.	FOLR2 FOLR3	5.23e-06	2	80	2	21783456
Pubmed	18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study.	FOLR2 FOLR3	5.23e-06	2	80	2	31824505
Pubmed	Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.	FOLR2 FOLR3	5.23e-06	2	80	2	11749123
Pubmed	TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models.	TLR2 MMP9	5.23e-06	2	80	2	25879213
Pubmed	Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation.	FOLR2 FOLR3	5.23e-06	2	80	2	25375039
Pubmed	The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer.	TBX3 TBX2	5.23e-06	2	80	2	23624936
Pubmed	Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts.	FOLR2 FOLR3	5.23e-06	2	80	2	12368056
Pubmed	Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.	FOLR2 FOLR3	5.23e-06	2	80	2	14745917
Pubmed	Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity.	FOLR2 FOLR3	5.23e-06	2	80	2	8110752
Pubmed	Feedback activation of neurofibromin terminates growth factor-induced Ras activation.	NF1 EGF	5.23e-06	2	80	2	26861207
Pubmed	Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.	TBX3 TBX2	5.23e-06	2	80	2	25394776
Pubmed	Folate modulates Hox gene-controlled skeletal phenotypes.	FOLR2 FOLR3	5.23e-06	2	80	2	15282741
Pubmed	TLR2 signaling directs NO-dependent MMP-9 induction in mouse microglia.	TLR2 MMP9	5.23e-06	2	80	2	24780563
Pubmed	ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases.	ZNRF1 ZNRF2	5.23e-06	2	80	2	14561866
Pubmed	Mapping of the human Lunatic Fringe (LFNG) gene to 7p22 and Manic Fringe (MFNG) to 22q12.	MFNG LFNG	5.23e-06	2	80	2	9878264
Pubmed	Complex functional redundancy of Tbx2 and Tbx3 in mouse limb development.	TBX3 TBX2	5.23e-06	2	80	2	35506352
Pubmed	Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome.	TBX3 TBX2	5.23e-06	2	80	2	10468588
Pubmed	Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9.	TLR2 MMP9	5.23e-06	2	80	2	20800577
Pubmed	The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.	TBX3 TBX2	5.23e-06	2	80	2	25371204
Pubmed	Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.	TLR2 MMP9	5.23e-06	2	80	2	24752463
Pubmed	BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.	MFNG RFNG LFNG	5.23e-06	15	80	3	16324690
Pubmed	Expression of Notch pathway genes in the embryonic mouse metanephros suggests a role in proximal tubule development.	MFNG RFNG LFNG	5.23e-06	15	80	3	12971992
Pubmed	Fine-tuning of Notch signaling sets the boundary of the organ of Corti and establishes sensory cell fates.	MFNG RFNG LFNG	5.23e-06	15	80	3	27966429
Pubmed	Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth.	MFNG RFNG LFNG	5.23e-06	15	80	3	12167404
Pubmed	Expression of Notch pathway components in fetal and adult mouse small intestine.	MFNG RFNG LFNG	6.42e-06	16	80	3	12617809
Pubmed	Defective Tbx2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice.	TBX3 CACNA1G TBX2	6.42e-06	16	80	3	21266775
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	TBC1D3 KLHL25 TBC1D3D RCBTB1 VPS35L ZNRF1 CCAR2 ZNF471 CFAP46 TBC1D3F	8.66e-06	750	80	10	11230166
Pubmed	Lunatic fringe null female mice are infertile due to defects in meiotic maturation.	MFNG RFNG LFNG	9.33e-06	18	80	3	15659488
Pubmed	Lunatic fringe potentiates Notch signaling in the developing brain.	MFNG RFNG LFNG	1.11e-05	19	80	3	20510365
Pubmed	T-box family reunion.	TBX3 TBX2	1.57e-05	3	80	2	9196325
Pubmed	Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction.	MFNG LFNG	1.57e-05	3	80	2	25808869
Pubmed	Fringe is a glycosyltransferase that modifies Notch.	MFNG LFNG	1.57e-05	3	80	2	10935626
Pubmed	Diversity of human copy number variation and multicopy genes.	TBC1D3E TBC1D3G	1.57e-05	3	80	2	21030649
Pubmed	Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells.	EGF MMP9	1.57e-05	3	80	2	21752154
Pubmed	Expression of Drosophila omb-related T-box genes in the developing human and mouse neural retina.	TBX3 TBX2	1.57e-05	3	80	2	11726608
Pubmed	Fringe modifies O-fucose on mouse Notch1 at epidermal growth factor-like repeats within the ligand-binding site and the Abruptex region.	MFNG LFNG	1.57e-05	3	80	2	12486116
Pubmed	Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.	EGF MMP9	1.57e-05	3	80	2	17397984
Pubmed	Renal tubular reabsorption of folate mediated by folate binding protein 1.	FOLR2 FOLR3	1.57e-05	3	80	2	15703271
Pubmed	Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies.	FOLR2 FOLR3	1.57e-05	3	80	2	15694460
Pubmed	CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.	FOLR2 FOLR3	1.57e-05	3	80	2	33563975
Pubmed	Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.	TBX3 TBX2	1.57e-05	3	80	2	20025935
Pubmed	Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development.	FOLR2 FOLR3	1.57e-05	3	80	2	10508523
Pubmed	[Expression of MMP-2, MMP-9 and collagen type IV and their relationship in colorectal carcinomas].	COL4A6 MMP9	1.57e-05	3	80	2	18782525
Pubmed	Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes.	MMP9 ACE	1.57e-05	3	80	2	20215707
Pubmed	TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence.	TBX3 TBX2	1.57e-05	3	80	2	11748239
Pubmed	EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth.	EGF MMP9	1.57e-05	3	80	2	20472833
Pubmed	Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells.	FOLR2 FOLR3	1.57e-05	3	80	2	8304978
Pubmed	Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement.	FOLR2 FOLR3	1.57e-05	3	80	2	1894617
Pubmed	Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia.	TLR2 MMP9	1.57e-05	3	80	2	18651887
Pubmed	Transgenic study of the function of chymase in heart remodeling.	MMP9 ACE	1.57e-05	3	80	2	12359984
Pubmed	Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta.	FOLR2 FOLR3	1.57e-05	3	80	2	9166787
Pubmed	Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family.	TBX3 TBX2	1.57e-05	3	80	2	8988164
Pubmed	FSL-1 induces MMP-9 production through TLR-2 and NF-κB /AP-1 signaling pathways in monocytic THP-1 cells.	TLR2 MMP9	1.57e-05	3	80	2	25200491
Pubmed	Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth.	FOLR2 FOLR3	1.57e-05	3	80	2	37928524
Pubmed	Expression patterns of folate binding proteins one and two in the developing mouse embryo.	FOLR2 FOLR3	1.57e-05	3	80	2	9973545
Pubmed	The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.	TBX3 TBX2	1.57e-05	3	80	2	12000749
Pubmed	Galactose differentially modulates lunatic and manic fringe effects on Delta1-induced NOTCH signaling.	MFNG LFNG	1.57e-05	3	80	2	22081605
Pubmed	ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.	MMP9 ACE	1.57e-05	3	80	2	23091417
Pubmed	Sequential Notch activation regulates ventricular chamber development.	MFNG RFNG LFNG	1.75e-05	22	80	3	26641715
Pubmed	Mycobacterium tuberculosis and Human Immunodeficiency Virus Type 1 Cooperatively Modulate Macrophage Apoptosis via Toll Like Receptor 2 and Calcium Homeostasis.	TLR2 XIAP	3.13e-05	4	80	2	26132135
Pubmed	Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.	TBX3 TBX2	3.13e-05	4	80	2	22284968
Pubmed	Identification of two putative novel folate receptor genes in humans and mouse.	FOLR2 FOLR3	3.13e-05	4	80	2	11111049
Pubmed	Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5Δ32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.	MMP9 ACE	3.13e-05	4	80	2	27533781
Pubmed	Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae.	TLR2 MMP9	3.13e-05	4	80	2	22697069
Pubmed	Evidence of a role for T-box genes in the evolution of limb morphogenesis and the specification of forelimb/hindlimb identity.	TBX3 TBX2	3.13e-05	4	80	2	8798150
Pubmed	Mycobacterium tuberculosis Upregulates TNF-α Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells.	TLR2 MMP9	3.13e-05	4	80	2	26367274
Pubmed	MMP2 and MMP9 are Associated with Apical Periodontitis Progression and Might be Modulated by TLR2 and MyD88.	TLR2 MMP9	3.13e-05	4	80	2	29267523
Pubmed	Growing Mouse Oocytes Transiently Activate Folate Transport via Folate Receptors As They Approach Full Size.	FOLR2 FOLR3	3.13e-05	4	80	2	27122634
Pubmed	Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.	TBX3 TBX2	3.13e-05	4	80	2	18829543
Pubmed	Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.	RFNG LFNG	3.13e-05	4	80	2	22624713
Pubmed	Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis.	MMP9 ACE	3.13e-05	4	80	2	22513045
Pubmed	Identification of candidate susceptibility and resistance genes of mice infected with Streptococcus suis type 2.	TLR2 MMP9	3.13e-05	4	80	2	22384161
Pubmed	Mutations in folate transporter genes and risk for human myelomeningocele.	FOLR2 FOLR3	3.13e-05	4	80	2	28948692
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.50e-15	149	80	11	chr17q12
Cytoband	17q12	TBC1D3 TBC1D3H TBC1D3C TBC1D3B TBC1D3F	8.90e-07	99	80	5	17q12
Cytoband	19q13.43	ZBTB45 ZNF471 ZNF446	4.86e-04	87	80	3	19q13.43
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL2 ZBTB45 KLHL25 RCBTB1 BACH2 KBTBD11	1.80e-06	134	50	6	861
GeneFamily	Beta 3-glycosyltransferases	MFNG RFNG LFNG	3.87e-05	24	50	3	426
GeneFamily	T-boxes	TBX3 TBX2	1.11e-03	18	50	2	766
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 ZBTB45 ZNF202 ZNF75D ZNF407 ZNF471 ZNF446	3.42e-03	718	50	7	28
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC8 TTC27 CFAP46	3.95e-03	115	50	3	769
GeneFamily	Kelch like\|BTB domain containing	KLHL2 KLHL25	6.01e-03	42	50	2	617
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.31e-11	90	76	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	COL4A6 TBC1D3 TBC1D3H TBC1D3L EGF ARSL TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	5.95e-11	242	76	12	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	COL4A6 TBC1D3 TBC1D3H TBC1D3L ARSL TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.59e-10	213	76	11	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	COL4A6 TBC1D3 TBC1D3H TBC1D3L ARSL TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.59e-10	213	76	11	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L ARSL TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	6.21e-08	281	76	10	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L ARSL TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	6.21e-08	281	76	10	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBX3 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	2.08e-07	320	76	10	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	COL4A6 TBX3 TBC1D3 TBC1D3H TBC1D3L EGF ARSL TBC1D3D NOTUM RFNG TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	1.20e-05	1153	76	15	PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	RCBTB1 BACH2 KBTBD11 ZNRF1 LFNG IL27RA	1.07e-04	210	76	6	GSM403995_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	ZHX3 PTPRO BACH2 XIAP	2.94e-04	89	76	4	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500	MFNG CLASP1 KBTBD11 ZDBF2 ACVR2B CBFA2T3 TMEM178B LFNG	3.25e-04	482	76	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	MTMR4 TBC1D3 TBC1D3H TBC1D3L TBC1D3D DHCR7 TRIM14 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F	3.30e-04	1049	76	12	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MFNG FOLR2 TLR2 KBTBD11 MMP9 STAB1	4.96e-07	163	80	6	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MFNG FOLR2 TLR2 KBTBD11 MMP9 STAB1	4.96e-07	163	80	6	5d49414432db259a19df50d7944581d00b69f537
ToppCell	droplet-Bladder-Unstain-18m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLR2 TLR2 MMP9 LFNG STAB1	9.74e-06	158	80	5	e5e7b2d609973f1dd4fe7dc62bb69422268ea801
ToppCell	facs-MAT-Fat-3m-Myeloid-myeloid_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9 STAB1	1.13e-05	163	80	5	5fc836444bc156c8248abee001b0ecbe43f980c9
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9 STAB1	1.51e-05	173	80	5	054f64462b648ba6b4b28b48c716dc01b2ddd790
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9 STAB1	1.51e-05	173	80	5	9a8fec9a08bb61456a4ea43ae1316bd3e197a773
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	FOLR2 ZNRF1 NME6 RFNG STAB1	1.60e-05	175	80	5	7de1023161233b64f11e130881c742f4cf2bff65
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Pericyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PPP1R3D TBX3 ARSL NOTUM TBX2	1.93e-05	182	80	5	a71054800e7696ae39b03b11aac2991fb5d54fad
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 KCNN2 ZNRF1 ACE TBX2	1.93e-05	182	80	5	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PPP1R3D TBX3 ARSL NOTUM TBX2	1.93e-05	182	80	5	406abe0e2958c73ff0f8bfbf7e6183dd6a53db0f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TBX3 NOTUM BACH2 FHL1 TBX2	2.20e-05	187	80	5	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 KCNN2 ZNRF1 ACE TBX2	2.43e-05	191	80	5	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	TBX3 KCNN2 ZNRF1 ACE TBX2	2.49e-05	192	80	5	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	Control-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	FOLR2 TLR2 ZNRF1 MMP9 STAB1	2.55e-05	193	80	5	2a6d531abd34df20941cf3dac4fdfb1621a1bde6
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBX3 KCNN2 FHL1 ACE TBX2	2.75e-05	196	80	5	a53caedd0103bd162b3aee8ab87b4442a5e0338f
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 MFNG BCAN TMEM178B TBX2	2.89e-05	198	80	5	c506334d81af672ef9ddc8c4fd2a790bdb58e63e
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ERO1B SMARCC1 ZNRF2 IL27RA STAB1	2.96e-05	199	80	5	bbb4798d6a24e756fea744a151ba67c1bafbac9a
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-2\|TCGA-Uvea / Sample_Type by Project: Shred V9	DYNC2H1 PRKCI ZDBF2 ACVR2B	1.06e-04	136	80	4	b460669c13ed43ff3885acd38ce18f75d693738d
ToppCell	COVID-19_Moderate-B_cell\|World / disease group, cell group and cell class	KLHL25 TBC1D3L BACH2 CATSPERB	1.15e-04	139	80	4	b93e1da87d44e55d75e8cc1b87c2970645679c01
ToppCell	COVID-19_Moderate-B_cell\|COVID-19_Moderate / disease group, cell group and cell class	KLHL25 TBC1D3L BACH2 CATSPERB	1.25e-04	142	80	4	88bb8d9bca66131df4ee7021b88248e146aa7aa6
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-intermediate_monocyte\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOLR3 TLR2 CACNA1G STAB1	1.25e-04	142	80	4	9b39c778cfaf457303010f1b1cae8c0cd8fe5d1d
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 ACE TBX2	1.26e-04	54	80	3	68c762094ea29e321a6fd4f6d9b598431023fa7b
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 ACE TBX2	1.26e-04	54	80	3	7816e6541e3a9e702f25bd102a95ce963ce31535
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DYNC2H1 ZNF75D FHL1 ZNF446	1.32e-04	144	80	4	3d880c140db4a0e7602bfddcb73a42a68c2848d5
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	ARSL TBC1D3D FOLR3 LFNG	1.32e-04	144	80	4	6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 BACH2 FHL1 TBX2	1.62e-04	152	80	4	621e9b33cd3bb1c7b7d0633069f286b203e3d9c0
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOLR3 TLR2 CACNA1G STAB1	1.62e-04	152	80	4	072daae0deb6cb92f126e4566f1d264cda9ed157
ToppCell	mild_COVID-19_(asymptomatic)-MAIT\|World / disease group, cell group and cell class (v2)	DYNC2H1 DHCR7 CATSPERB ZDBF2	1.66e-04	153	80	4	2b4c69f6db17927d6506a645ac058133e60b0103
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A6 TBX3 BACH2 TBX2	1.66e-04	153	80	4	1524557514668f515ac1bbe847611f564b265b42
ToppCell	mild_COVID-19_(asymptomatic)-MAIT\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	DYNC2H1 DHCR7 CATSPERB ZDBF2	1.66e-04	153	80	4	26852f3d8f80e102e24bcb90e24aac26fdc9a32c
ToppCell	(2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell\|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization)	ZNRF1 TRIM14 ZNRF2 LFNG	1.71e-04	154	80	4	059bdf6843f94f5028d4df6aa025865a9edb4521
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	TBX3 KCNN2 ACE TBX2	1.84e-04	157	80	4	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYB5RL FOLR2 MMP9 STAB1	1.88e-04	158	80	4	9a6d9b541446a6aa9f8ed040b330dbb5c6447076
ToppCell	droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYB5RL FOLR2 MMP9 STAB1	1.88e-04	158	80	4	2438713d2a7e32c647ab3384237ed614f4ec8fec
ToppCell	droplet-Bladder-nan-24m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLR2 TLR2 MMP9 STAB1	1.88e-04	158	80	4	4a9d4706876f6e86fc5d63ad6dc7df1b4a5cfd9e
ToppCell	droplet-Bladder-Unstain-18m-Hematologic-leukocyte\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLR2 TLR2 MMP9 STAB1	1.93e-04	159	80	4	89b5e895e95cdd654edd471bde9b6887939b3503
ToppCell	droplet-Bladder-Unstain-18m-Hematologic\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLR2 TLR2 MMP9 STAB1	1.93e-04	159	80	4	a80b4637a74bcc6f213d584aba2c727a983eedb3
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9	2.02e-04	161	80	4	787f91f906756ef570c0d02936c3cdfafb3f7454
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9	2.02e-04	161	80	4	3db97af49520dc8cbafb4454d8afd9d588160e89
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 MMP9	2.02e-04	161	80	4	f1d258c81bcf0f3c52bd20aa58faa9a5fd888168
ToppCell	droplet-Bladder-nan-3m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO TLR2 MMP9 STAB1	2.07e-04	162	80	4	0cee9ef405765f3f82d0cd7b8adc88f6e9fdbb5c
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYB5RL TRIM14 LFNG IL27RA	2.07e-04	162	80	4	58fe827198c172eeaa26273b0fad7991a718b0bf
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 STAB1	2.22e-04	165	80	4	518ee34c18065100a2f2c6e407d3a7866b908593
ToppCell	droplet-Lung-nan-18m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO CBFA2T3 ACE RPL3L	2.22e-04	165	80	4	e32697321cef424c2ad4e11ee9da3e510d5ce505
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 STAB1	2.22e-04	165	80	4	becb8f726b84509ec29c75b530a3fe757651301d
ToppCell	severe-HSPC\|severe / disease stage, cell group and cell class	ZNRF1 CBFA2T3 FHL1 ZNF471	2.22e-04	165	80	4	acd837d88ad3786c263f74651a6c0e02fa2fa2c5
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 STAB1	2.22e-04	165	80	4	ae8dd9c00f96590f27ed21cd6314f4577e00e312
ToppCell	droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO CBFA2T3 ACE RPL3L	2.22e-04	165	80	4	0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09
ToppCell	facs-Heart-LA-24m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 MMP9 STAB1	2.27e-04	166	80	4	2c931d593e189127c31adaf36a3df81d8287bb53
ToppCell	facs-Heart-LA-24m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 MMP9 STAB1	2.27e-04	166	80	4	9e7a9cb7beeb7015fcaa476a4902883dee99e8c0
ToppCell	facs-Heart-LA-24m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 MMP9 STAB1	2.27e-04	166	80	4	2a3c396deb068066b8c2f85ddd2fa52629776bcd
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	TBX3 KCNN2 ACE TBX2	2.32e-04	167	80	4	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRO CBFA2T3 ACE RPL3L	2.38e-04	168	80	4	00cff4698db14e03ca1d1b409e5ed1ad23b12615
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 BCAN TMEM178B TBX2	2.38e-04	168	80	4	948d9e9972bd2a4b503d55fa69b70dd568a35a67
ToppCell	facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRO FOLR2 TLR2 STAB1	2.43e-04	169	80	4	8180aeda13c511260d0542a94156059d558848a7
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRO CBFA2T3 ACE RPL3L	2.43e-04	169	80	4	90c00ab30e582b0e2a2be751e1fae9024cfb9ea6
ToppCell	severe-HSPC\|World / disease stage, cell group and cell class	ZNRF1 CBFA2T3 FHL1 ZNF471	2.43e-04	169	80	4	b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 BCAN ACE TBX2	2.49e-04	170	80	4	f0b0d2d0402de3ed7322284a599646db43475761
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRO FOLR2 TLR2 STAB1	2.49e-04	170	80	4	f524b73d65941ebef7671c46df4362a3f15d24fc
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TBX3 BCAN ACE TBX2	2.49e-04	170	80	4	054360a3b05f5e41221c98b122d241b1affad26a
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FOLR2 TLR2 MMP9 STAB1	2.49e-04	170	80	4	e028e22ad051c2628248b212b5d28b891e0ee782
ToppCell	facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRO FOLR2 TLR2 STAB1	2.54e-04	171	80	4	26755e43d94e934106fc19ab929e4d34c17d6cba
ToppCell	control-Myeloid-Mast_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MFNG CBFA2T3 FHL1 STAB1	2.60e-04	172	80	4	c1c99e6732234a6649a79610e99390db0c8f19b0
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	FOLR2 VPS35L ZNRF2 STAB1	2.60e-04	172	80	4	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PTPRO FOLR2 MMP9 STAB1	2.60e-04	172	80	4	9a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MFNG KBTBD11 MMP9 IL27RA	2.60e-04	172	80	4	425970e9ce8943f7e2ba6ca958e7a3a29baa798c
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MFNG KBTBD11 MMP9 IL27RA	2.60e-04	172	80	4	ca0cc0e92b6cdce5016f18fcb2ec1508cb222502
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	SMG8 BCAN RFNG LFNG	2.66e-04	173	80	4	d4cbeae262abfa30d8c5452285d3261a96875610
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRO FOLR2 TLR2 STAB1	2.66e-04	173	80	4	a664dbd7fb55b1c4309fa5f9425bc83924dac545
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZHX3 CLASP1 CCAR2 ACVR2B	2.72e-04	174	80	4	a1f745962a104c6f4b86b7e482da8755384c773a
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TBX3 MFNG ZNF407 ACE	2.72e-04	174	80	4	cb0109661e8c9ca04d67d33f2d926f0e649bf67d
ToppCell	Tuft-tuft-4\|World / Class top	KLHL2 FOLR2 ZNF202 TMEM178B	2.72e-04	174	80	4	d6f306ebf66061bf9e9742000bfedce12d277452
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 BCAN TMEM178B TBX2	2.72e-04	174	80	4	412ccc099028a372b9d953363984c2da54b2187f
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG8 NME6 ACE RPL3L	2.78e-04	175	80	4	c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TBX3 BCAN FHL1 LFNG	2.78e-04	175	80	4	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FOLR2 TLR2 MMP9 STAB1	2.84e-04	176	80	4	98176bf3c961d5262593e2d5d002836adb010e13
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOLR2 TLR2 MMP9 STAB1	2.90e-04	177	80	4	f28243b51be104cb3adcde63f03fc2206ed3121e
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	CATSPERB BCAN FHL1 TBX2	2.90e-04	177	80	4	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CATSPERB BCAN FHL1 TBX2	2.90e-04	177	80	4	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FOLR2 TLR2 CACNA1G STAB1	2.96e-04	178	80	4	24e8c62060455159235985f456af0c5023a7f3f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FOLR2 TLR2 CACNA1G STAB1	2.96e-04	178	80	4	4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FOLR2 MMP9 TBX2 STAB1	2.96e-04	178	80	4	30d2b54462fd16222ad2e3806be6143e834b29e0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYB5RL FOLR2 ZNF446 STAB1	3.03e-04	179	80	4	2c3abd646d2c8992e8ff76a824eab5beba8ba4c6
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYB5RL FOLR2 ZNF446 STAB1	3.03e-04	179	80	4	6eb84fe9691ad40127b2d1f1c672428333c8fab4
ToppCell	ASK454-Endothelial-Lymphatic\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	VPS35L KBTBD11 CBFA2T3 ZNF471	3.03e-04	179	80	4	fd84a79f76a01c0377dff5b20016b004d369f96f
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	TBX3 KCNN2 ACE TBX2	3.09e-04	180	80	4	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD11 ZNRF1 LFNG IL27RA	3.09e-04	180	80	4	978728c89497d26287f73974fb738ad9fde61415
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBX3 MFNG ZNRF1 ACE	3.09e-04	180	80	4	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	(2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	ZNRF1 TRIM14 ZNRF2 LFNG	3.16e-04	181	80	4	ad14c7111d4fb924afd233cb114447f195373a7c
ToppCell	facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD11 ZNRF1 LFNG IL27RA	3.16e-04	181	80	4	be7c7db6b99603759593e6f79cdcaa4bbf234cb7
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 BCAN TMEM178B TBX2	3.22e-04	182	80	4	d6740bca2b974122b8451989365a94a81140afd1
ToppCell	facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD11 ZNRF1 LFNG IL27RA	3.22e-04	182	80	4	da3e9093cba791c7c282eb044656046252a32789
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTPRO FOLR2 TLR2 STAB1	3.22e-04	182	80	4	de15a77b8d3527638bea5b04e0b2af03ac93bc18
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FOLR2 TLR2 MMP9 STAB1	3.36e-04	184	80	4	d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	BACH2 TMEM178B ZNRF2 TBC1D3C	3.36e-04	184	80	4	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD11 MMP9 LFNG IL27RA	3.36e-04	184	80	4	8fc047977fad38fcd26eebcc279a688efd342ed8
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KBTBD11 ZNRF1 LFNG IL27RA	3.36e-04	184	80	4	c37c623c4a5ff1628486d8a6461fa355ad5c264c
ToppCell	droplet-Marrow-nan-21m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFNG FHL1 LFNG IL27RA	3.36e-04	184	80	4	7e129862f8d2353387999e633725325c4d8cb42e
ToppCell	356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	TBX3 KCNN2 ACE TBX2	3.50e-04	186	80	4	f0b78c7ee20279970ea8961bf59acb5262f2dce5
ToppCell	P28-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TBX3 MFNG ACE TBX2	3.50e-04	186	80	4	a38f84f478798951c8798c8e90e4897c729cf630
Drug	Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	COL4A6 EGF ARSL PTPRO CACNA1G FHL1 RPL3L	3.63e-06	200	73	7	5497_UP
Drug	Folic Acid	FOLR2 FOLR3	1.01e-05	2	73	2	DB00158
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPP1R3D NME6 ACVR2B CBFA2T3 IL27RA TBX2	1.91e-05	172	73	6	2794_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPP1R3D NF1 NME6 CBFA2T3 IL27RA TBX2	2.17e-05	176	73	6	2639_DN
Drug	Captopril	MMP9 ACE	3.04e-05	3	73	2	DB01197
Drug	Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A	TLR2 KBTBD11 KCNN2 TTC27 TRIM14 IL27RA	3.34e-05	190	73	6	3041_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	ZHX3 NF1 ZNF202 RFNG TRIM14 STAB1	3.65e-05	193	73	6	3474_UP
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	COL4A6 KLHL25 NF1 ERO1B ZNF407 TBX2	3.86e-05	195	73	6	4092_DN
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	ZNF75D ZNF407 MMP9 TRIM14 ZNF446 IL27RA	3.97e-05	196	73	6	4101_DN
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A	KLHL25 NF1 ZNF407 CACNA1G FHL1 ZNF446	3.97e-05	196	73	6	5251_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A	COL4A6 KLHL25 NF1 ERO1B MUC5B BCAN	3.97e-05	196	73	6	3702_DN
Drug	Tolazamide [1156-19-0]; Down 200; 12.8uM; HL60; HT_HG-U133A	NF1 ERO1B UNC45A MMP9 TRIM14 IL27RA	3.97e-05	196	73	6	2482_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	PPP1R3D COL4A6 VPS35L UNC45A FHL1 TBX2	3.97e-05	196	73	6	5806_DN
Drug	Dactinomycin	EGF XIAP CACNA1G MMP9 FHL1 ACE IL27RA	4.02e-05	290	73	7	ctd:D003609
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ZHX3 CLASP1 KBTBD11 ZNF202 CBFA2T3 FHL1	4.09e-05	197	73	6	4137_DN
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ZHX3 CYB5RL ERO1B BACH2 TLR2 TRIM14	4.09e-05	197	73	6	2103_UP
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A	CYB5RL NF1 SMARCC1 UNC45A ACVR2B MMP9	4.09e-05	197	73	6	1780_DN
Drug	Cefalonium [5575-21-3]; Up 200; 8.8uM; PC3; HT_HG-U133A	COL4A6 ZHX3 NF1 PTPRO ZNF75D TRIM14	4.09e-05	197	73	6	4245_UP
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; PC3; HT_HG-U133A	PPP1R3D MFNG ERO1B BACH2 ZNF75D TRIM14	4.21e-05	198	73	6	4258_DN
Drug	3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A	PPP1R3D ZHX3 KLHL25 EGF BCAN ZNF446	4.33e-05	199	73	6	6407_UP
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PPP1R3D NF1 DYNC2H1 SMARCC1 UNC45A MMP9	4.33e-05	199	73	6	5464_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; PC3; HT_HG-U133A	PPP1R3D EGF VPS35L ZNF75D UNC45A FHL1	4.33e-05	199	73	6	6342_DN
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	PPP1R3D NF1 VPS35L ACVR2B ZNF446 TBX2	4.45e-05	200	73	6	6612_DN
Drug	NSC612475	EGF ACE	6.06e-05	4	73	2	CID000003412
Drug	dienol	TBX3 MFNG NOTUM RFNG LFNG	7.66e-05	136	73	5	CID000003049
Drug	DIPSO	EGF ACE	1.01e-04	5	73	2	CID000100210
Drug	rhamnose	MFNG EGF BCAN MMP9 RFNG ACE LFNG	1.45e-04	356	73	7	CID000000840
Drug	2,5-dichlorophenol	COQ6 ACE	1.51e-04	6	73	2	CID000000066
Drug	4-aminophenylmercuriacetate	MMP9 ACE	1.51e-04	6	73	2	ctd:C010024
Drug	anacardic acid	EGF XIAP MMP9	1.92e-04	35	73	3	ctd:C088115
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPP1R3D ZNF202 CBFA2T3 IL27RA TBX2	2.18e-04	170	73	5	4153_DN
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	CYB5RL KBTBD11 CBFA2T3 TRIM14 IL27RA	2.30e-04	172	73	5	2195_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	TBX3 KLHL25 ERO1B EGF ZNF446	2.43e-04	174	73	5	5248_UP
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; HL60; HT_HG-U133A	MFNG TLR2 KCNN2 CBFA2T3 TRIM14	2.49e-04	175	73	5	2938_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	TBX3 NME6 ACVR2B TRIM14 IL27RA	2.49e-04	175	73	5	4072_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	PPP1R3D VPS35L CBFA2T3 IL27RA TBX2	2.56e-04	176	73	5	6980_DN
Drug	11-deoxojervine	TBX3 EGF DHCR7 LFNG TBX2	2.56e-04	176	73	5	CID000020518
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ZNF75D UNC45A CBFA2T3 IL27RA TBX2	2.63e-04	177	73	5	7550_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; HL60; HT_HG-U133A	MFNG KBTBD11 TTC27 CBFA2T3 TRIM14	2.70e-04	178	73	5	2977_DN
Drug	N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide	TBX3 XIAP	2.80e-04	8	73	2	ctd:C058815
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; HL60; HG-U133A	MFNG KBTBD11 SMARCC1 CBFA2T3 TRIM14	2.84e-04	180	73	5	1626_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; HL60; HT_HG-U133A	MTMR4 CYB5RL KBTBD11 UNC45A CBFA2T3	3.30e-04	186	73	5	2192_DN
Drug	15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A	MFNG KBTBD11 TTC27 FHL1 TRIM14	3.39e-04	187	73	5	6190_DN
Drug	Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A	ERO1B ZNF407 FHL1 TRIM14 STAB1	3.39e-04	187	73	5	3386_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A	NF1 ERO1B ZNF407 ZNF471 STAB1	3.56e-04	189	73	5	5455_UP
Drug	Amitrole	TBX3 MMP9 ACE	3.56e-04	43	73	3	ctd:D000640
Drug	platycodin D	EGF MMP9	3.60e-04	9	73	2	ctd:C108953
Drug	Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; HL60; HT_HG-U133A	CYB5RL DYNC2H1 RCBTB1 CBFA2T3 TRIM14	3.64e-04	190	73	5	2456_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ZHX3 TTC27 NME6 ACVR2B IL27RA	3.82e-04	192	73	5	458_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	NF1 EGF KCNN2 RPL3L IL27RA	3.91e-04	193	73	5	5271_UP
Drug	Betamethasone [378-44-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PPP1R3D MTMR4 NF1 SMARCC1 NME6	4.01e-04	194	73	5	5328_DN
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A	ZHX3 KLHL25 ERO1B ZNF407 ZNF471	4.01e-04	194	73	5	6457_UP
Drug	rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A	TLR2 ZNF202 UNC45A MMP9 IL27RA	4.01e-04	194	73	5	5932_DN
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	PPP1R3D COL4A6 EGF BACH2 ZNF75D	4.01e-04	194	73	5	7379_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A	NF1 VPS35L UNC45A ACVR2B TBX2	4.01e-04	194	73	5	2100_UP
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	COL4A6 NF1 ZNF202 UNC45A ZNF446	4.01e-04	194	73	5	4455_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	PPP1R3D CLASP1 ZNF75D RFNG IL27RA	4.01e-04	194	73	5	7446_DN
Drug	LY-171,883; Down 200; 1uM; MCF7; HG-U133A	NF1 ACVR2B FHL1 TRIM14 STAB1	4.01e-04	194	73	5	222_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PPP1R3D ZNF202 UNC45A MMP9 RFNG	4.10e-04	195	73	5	910_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	ERO1B TLR2 FHL1 ZNF446 STAB1	4.20e-04	196	73	5	5253_UP
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	KLHL25 KCNN2 ZNF202 MUC5B FHL1	4.20e-04	196	73	5	5230_UP
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A	KLHL25 NF1 CACNA1G BCAN LFNG	4.20e-04	196	73	5	2494_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NF1 TLR2 UNC45A FHL1 ZNF446	4.20e-04	196	73	5	3872_DN
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A	COL4A6 TBX3 NF1 MUC5B FHL1	4.20e-04	196	73	5	6101_UP
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	NF1 MUC5B FHL1 ZNF446 LFNG	4.20e-04	196	73	5	2233_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	KLHL25 TLR2 KBTBD11 KCNN2 FHL1	4.20e-04	196	73	5	5583_UP
Drug	Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A	COL4A6 KLHL25 ERO1B TLR2 TRIM14	4.20e-04	196	73	5	2101_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	COL4A6 ZHX3 KLHL25 TLR2 BCAN	4.20e-04	196	73	5	3796_DN
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	RCBTB1 KBTBD11 UNC45A ZNF446 TBX2	4.20e-04	196	73	5	7310_UP
Drug	Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NF1 DYNC2H1 FHL1 TRIM14 ZNF446	4.20e-04	196	73	5	2627_DN
Drug	5152487; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CYB5RL NF1 ACVR2B FHL1 RFNG	4.20e-04	196	73	5	896_DN
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ZNF75D ACVR2B RFNG TRIM14 IL27RA	4.20e-04	196	73	5	7029_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A	PPP1R3D NF1 COQ6 RPL3L IL27RA	4.20e-04	196	73	5	2389_UP
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; PC3; HT_HG-U133A	NF1 BACH2 ZNF202 TRIM14 TBX2	4.20e-04	196	73	5	2112_UP
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	NF1 SMARCC1 ACVR2B RFNG IL27RA	4.20e-04	196	73	5	3420_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	COL4A6 KLHL25 ZNF202 ZNF446 TBX2	4.20e-04	196	73	5	3816_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DYNC2H1 TLR2 KBTBD11 RFNG TRIM14	4.20e-04	196	73	5	2889_DN
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A	COL4A6 ZHX3 BCAN TRIM14 ZNF446	4.20e-04	196	73	5	3668_UP
Drug	Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	NF1 ERO1B EGF MUC5B STAB1	4.20e-04	196	73	5	3331_UP
Drug	Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A	NF1 ERO1B EGF KBTBD11 FHL1	4.20e-04	196	73	5	2778_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A	MTMR4 DYNC2H1 KCNN2 CBFA2T3 TRIM14	4.30e-04	197	73	5	2439_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	PPP1R3D MFNG TTC27 UNC45A CBFA2T3	4.30e-04	197	73	5	1732_DN
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A	KLHL25 NF1 KBTBD11 ZNF202 TRIM14	4.30e-04	197	73	5	2782_UP
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; PC3; HT_HG-U133A	COL4A6 ZHX3 KLHL25 MMP9 TRIM14	4.30e-04	197	73	5	4639_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A	ZNF202 ZNF407 FHL1 TRIM14 STAB1	4.30e-04	197	73	5	6803_UP
Drug	Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A	PPP1R3D ZHX3 KLHL2 CYB5RL MMP9	4.30e-04	197	73	5	7164_DN
Drug	Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A	PPP1R3D KLHL25 NF1 ZNF407 RPL3L	4.30e-04	197	73	5	1496_UP
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A	NF1 ERO1B NOX3 MUC5B MMP9	4.30e-04	197	73	5	4715_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NF1 KCNN2 SMARCC1 ZNF202 FHL1	4.30e-04	197	73	5	3314_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	MFNG TLR2 KBTBD11 TRIM14 ZNF446	4.30e-04	197	73	5	3831_DN
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A	MTMR4 RCBTB1 SMARCC1 UNC45A NDUFB7	4.30e-04	197	73	5	6277_DN
Drug	DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A	KLHL25 NF1 ACVR2B IL27RA STAB1	4.30e-04	197	73	5	7543_DN
Drug	Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A	ZNF407 ZNF471 TRIM14 IL27RA STAB1	4.30e-04	197	73	5	3138_UP
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	COL4A6 KLHL25 EGF KCNN2 BCAN	4.30e-04	197	73	5	3635_DN
Drug	Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A	NF1 ARSL BACH2 ACE TBX2	4.30e-04	197	73	5	5099_UP
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	NF1 ERO1B DYNC2H1 UNC45A RFNG	4.30e-04	197	73	5	2698_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; PC3; HT_HG-U133A	NF1 ERO1B ACE ZNF471 TBX2	4.40e-04	198	73	5	6725_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A	KLHL25 TLR2 MMP9 ACE TRIM14	4.40e-04	198	73	5	2107_UP
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MFNG KLHL25 UNC45A IL27RA TBX2	4.40e-04	198	73	5	6508_DN
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	NF1 ERO1B EGF TLR2 FHL1	4.40e-04	198	73	5	5592_UP
Disease	lung disease (implicated_via_orthology)	TLR2 MMP9 ACE	3.59e-06	13	70	3	DOID:850 (implicated_via_orthology)
Disease	sinusitis (is_marker_for)	TLR2 MUC5B MMP9	1.02e-05	18	70	3	DOID:0050127 (is_marker_for)
Disease	pancreatic ductal carcinoma (is_marker_for)	EGF MUC5B MMP9 ACE	1.37e-05	61	70	4	DOID:3587 (is_marker_for)
Disease	Neurofibromatosis 3	NF1 COQ6	5.52e-05	5	70	2	C0917817
Disease	Staphylococcus aureus infection	TLR2 ACE	5.52e-05	5	70	2	C1318973
Disease	Staphylococcal Infections	TLR2 ACE	5.52e-05	5	70	2	C0038160
Disease	abdominal aortic aneurysm (implicated_via_orthology)	MMP9 ACE	1.98e-04	9	70	2	DOID:7693 (implicated_via_orthology)
Disease	cholesteatoma (is_marker_for)	TLR2 MMP9	2.47e-04	10	70	2	DOID:869 (is_marker_for)
Disease	otitis media (is_marker_for)	TLR2 MUC5B	2.47e-04	10	70	2	DOID:10754 (is_marker_for)
Disease	glomerulosclerosis (implicated_via_orthology)	MMP9 ACE	3.01e-04	11	70	2	DOID:0050851 (implicated_via_orthology)
Disease	obstructive sleep apnea (is_implicated_in)	MMP9 ACE	3.01e-04	11	70	2	DOID:0050848 (is_implicated_in)
Disease	colorectal cancer (is_marker_for)	TBX3 SMARCC1 XIAP MMP9	5.38e-04	157	70	4	DOID:9256 (is_marker_for)
Disease	cholesteatoma of middle ear (is_marker_for)	TLR2 MMP9	6.52e-04	16	70	2	DOID:10964 (is_marker_for)
Disease	hypertrophic cardiomyopathy (is_marker_for)	MMP9 FHL1	7.37e-04	17	70	2	DOID:11984 (is_marker_for)
Disease	renal fibrosis (implicated_via_orthology)	TLR2 ACE	7.37e-04	17	70	2	DOID:0050855 (implicated_via_orthology)
Disease	dermatomyositis (is_marker_for)	TLR2 MMP9	7.37e-04	17	70	2	DOID:10223 (is_marker_for)
Disease	Gastric ulcer	EGF MMP9	8.28e-04	18	70	2	C0038358
Disease	Glioblastoma	NF1 EGF MMP9	8.89e-04	79	70	3	C0017636
Disease	CCL4 measurement	TBC1D3 TBC1D3F	1.03e-03	20	70	2	EFO_0004751
Disease	Giant Cell Glioblastoma	NF1 EGF MMP9	1.06e-03	84	70	3	C0334588
Disease	Reperfusion Injury	EGF TLR2 MMP9	1.25e-03	89	70	3	C0035126
Disease	nephrotic syndrome (implicated_via_orthology)	COQ6 ACE	1.48e-03	24	70	2	DOID:1184 (implicated_via_orthology)
Disease	glioblastoma (is_implicated_in)	EGF MMP9	1.48e-03	24	70	2	DOID:3068 (is_implicated_in)
Disease	Cerebral Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0750935
Disease	Intracranial Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0750936
Disease	Pilocytic Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0334583
Disease	Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0004114
Disease	Juvenile Pilocytic Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0280783
Disease	Diffuse Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0280785
Disease	Grade I Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0205768
Disease	Mixed oligoastrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0547065
Disease	Childhood Cerebral Astrocytoma	NF1 MMP9	1.61e-03	25	70	2	C0338070
Disease	Gemistocytic astrocytoma	NF1 MMP9	1.74e-03	26	70	2	C0334581
Disease	Protoplasmic astrocytoma	NF1 MMP9	1.74e-03	26	70	2	C0334580
Disease	Fibrillary Astrocytoma	NF1 MMP9	1.74e-03	26	70	2	C0334582
Disease	Anaplastic astrocytoma	NF1 MMP9	1.87e-03	27	70	2	C0334579
Disease	Cerebral Hemorrhage	MMP9 ACE	2.02e-03	28	70	2	C2937358
Disease	primary biliary cholangitis (biomarker_via_orthology)	MMP9 ACE	2.02e-03	28	70	2	DOID:12236 (biomarker_via_orthology)
Disease	chloride measurement	CLASP1 TBX2	2.16e-03	29	70	2	EFO_0009284
Disease	Ciliopathies	TTC8 DYNC2H1 ACVR2B	2.30e-03	110	70	3	C4277690
Disease	Glioblastoma Multiforme	NF1 EGF MMP9	2.36e-03	111	70	3	C1621958

Protein segments in the cluster

Peptide	Gene	Start	Entry
FFDANWCGYLHRRDL	CCAR2	711	Q8N163
EAYRAEWKLCRSARH	C22orf39	51	Q6P5X5
HRAVLAACSEYFWQA	BACH2	51	Q9BYV9
EVCHYARRNDKSYWL	COL4A6	1531	Q14031
YCERFLHAARWHQRD	ARSL	456	P51690
LWYNERCFANREHFE	CATSPERB	296	Q9H7T0
EVVCHASAWDFYNRK	ACE	356	P12821
FIDWARYDDSRDHFC	ERO1B	151	Q86YB8
NRGRFTYLCAKAWHH	CFAP46	541	Q8IYW2
FGAWDHICNMRYRAF	COQ6	101	Q9Y2Z9
RDEHRCASKYGRDWE	DHCR7	446	Q9UBM7
SVENENYARHWCSRL	MUC5B	611	Q9HC84
RCEHFRSMFQSYWNE	RCBTB1	391	Q8NDN9
ESGRKWFCHVDDDNY	RFNG	136	Q9Y644
QGACYKHFSTRRSWE	BCAN	696	Q96GW7
YRWCATTANYDRDKL	MMP9	311	P14780
RWRKLYCANGHTFQA	PRKCI	131	P41743
SGRKWFCHVDDDNYV	LFNG	191	Q8NES3
AWTVRACERYHDQQD	KCNN2	326	Q9H2S1
CVFDLYHRDLARWEA	CYB5RL	36	Q6IPT4
FHYRRCQEAAWTLLE	IL27RA	166	Q6UWB1
KDTSRLYNFNWDHCG	FOLR3	76	P41439
NAARYCGSFCQHRDW	CBFA2T3	571	O75081
NFLACKQERHDWDYC	NDUFB7	76	P17568
YNCDCEFWLAKRRHH	MTMR4	1121	Q9NYA4
EEQDDWACRHFRINY	PTPRO	1071	Q16827
WACRHFRINYADEMQ	PTPRO	1076	Q16827
GWFLDNKQYRHTDCV	NOTUM	266	Q6P988
YKNRFWHDTCFRCAK	FHL1	56	Q13642
SLAWFHAACQERRNY	DYNC2H1	3866	Q8NCM8
SDAHQCRRLYEFSWR	KLHL25	156	Q9H0H3
NKSDCAEASYRWVRH	CACNA1G	1451	O43497
RKYCEDVNECAFWNH	EGF	351	P01133
DTSRLYNFNWDHCGK	FOLR2	71	P14207
RWFCHVDDDNYVNPR	MFNG	136	O00587
YKFWSNGHQLCEERS	SMG8	556	Q8ND04
WYETDARKHRDRCKA	TMEM178B	31	H3BS89
IAADDCRYKFHNSRW	TBX3	156	O15119
SDECRRRFYKDWHKS	RPL3L	111	Q92901
HYDFRQSCWVRAISQ	TBC1D3L	471	B9A6J9
LHNITFCRDRYAEWQ	NOX3	236	Q9HBY0
SWFDYNCIHVIERRA	SMARCC1	456	Q92922
AVYCFHAAAGEWREL	KBTBD11	326	O94819
GEQDKRLHCYASWRN	ACVR2B	51	Q13705
EARIEARKCYWGFHS	CLASP1	501	Q7Z460
ARKCYWGFHSHFSRE	CLASP1	506	Q7Z460
HYDFRQSCWVRAISQ	TBC1D3B	471	A6NDS4
HYDFRQSCWVRAISQ	TBC1D3H	471	P0C7X1
HEAQRWHFDFKNYRC	WFDC8	106	Q8IUA0
YHKGCIDEWFEVNRS	ZNRF2	221	Q8NHG8
AWSYFRRRKFQLCAD	TTC8	11	Q8TAM2
HQCAVCWRSFSLRDY	ZBTB45	431	Q96K62
WHSRNRNYKAEFASC	VPS35L	6	Q7Z3J2
VRCFSCHAAVDRWQY	XIAP	61	P98170
HYDFRQSCWVRAISQ	TBC1D3F	471	A6NER0
DDCRYKFHNSRWMVA	TBX2	161	Q13207
RHHSWDNDIRFICKY	ZDBF2	2031	Q9HCK1
WRKEDCQRFYREHEG	NME6	51	O75414
NCNSWVREYTKYHER	NF1	1681	P21359
YWDNNDHRDYSLTCR	PPP1R3D	266	O95685
GARKNLSERWDAYCF	STAB1	2286	Q9NY15
HYDFRQSCWVRAISQ	TBC1D3E	471	A0A087X179
DHHWKCARALANLAY	TTC23L	106	Q6PF05
RRHFCSDCGRAFDWK	ZNF446	421	Q9NWS9
VLARDCFATGRHYWE	TRIM14	311	Q14142
ESACRHFWSFRYHEA	ZNF75D	46	P51815
CGKAFRYNTSFIRHW	ZNF471	351	Q9BX82
HYDFRQSCWVRAISQ	TBC1D3D	471	A0A087WVF3
WCDYRSNCAENIRKH	ZNF407	1746	Q9C0G0
DHSCYDKAWELSRYR	TTC27	511	Q6P3X3
HYDFRQSCWVRAISQ	TBC1D3G	471	Q6DHY5
HYDFRQSCWVRAISQ	TBC1D3	471	Q8IZP1
WFSDRRYHCRNLKGS	ZHX3	541	Q9H4I2
EWCKYELDFSHFRLF	TLR2	711	O60603
YRCDDCGKHFRWTSD	ZNF202	481	O95125
HYDFRQSCWVRAISQ	TBC1D3K	471	A0A087X1G2
FHRLCENYIKSWFEG	UNC45A	391	Q9H3U1
YHKSCIDSWFEVNRS	ZNRF1	206	Q8ND25
HYDFRQSCWVRAISQ	TBC1D3I	471	A0A087WXS9
HYDFRQSCWVRAISQ	TBC1D3C	471	Q6IPX1
FYRKLCNNTDASADW	WDR64	76	B1ANS9
RSVECYDFKEERWHQ	KLHL2	321	O95198